Marla Shapiro, MDCM, explains how OPTION-VMS actigraphy data corroborated patient-reported sleep improvements with fezolinetant (Veozah) as early as week 4.
Marla Shapiro, CM, MDCM, CCFP, MHSc, FRCPC, FCFP, MSCP
Advertisement
Articles by Marla Shapiro, CM, MDCM, CCFP, MHSc, FRCPC, FCFP, MSCP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Low birth volume and unprofitability associated with obstetric services losses
2
IMS: Fezolinetant's improvements in sleep quality, hot flashes as early as week 4
3
Wen Shen, MD, highlights pregnancy, comorbidity history in perimenopause care
4
Top headlines in women's health from September 2026
5